MARKET

CASBF

CASBF

Cansino Biologic
OTCPK

Real-time Quotes | Nasdaq Last Sale

10.85
0.00
0.00%
Closed 16:00 06/30 EDT
OPEN
--
PREV CLOSE
10.85
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
54.00
52 WEEK LOW
8.78
MARKET CAP
1.44B
P/E (TTM)
8.92
1D
5D
1M
3M
1Y
5Y
BRIEF-Cansino Biologics Terminates Marketing Cooperation With Pfizer Over MCV4 Vaccine Product
reuters.com · 06/05 08:47
BRIEF-JPMorgan Chase & Co's Long Position In H-Share Of CanSino Biologics Rises To 11.13% - HKEX Filing
reuters.com · 05/27 09:23
BRIEF-Solution Group Says Solution Biologics Entered MoU With National Institutes Of Biotechnology Malaysia And Cansino Biologics Inc
reuters.com · 05/25 10:21
BRIEF-CanSino Biologics Plans A-Share Private Placement To Boost Capital
reuters.com · 05/25 10:05
BRIEF-LAV Management's Long Position In H-Share Of CanSino Biologics Falls To 0% - HKEX Filing
reuters.com · 05/25 09:19
BRIEF-The Capital Group Companies Inc's Long Position In H-Share Of CanSino Biologics Rises To 23.87% - Filing
reuters.com · 05/25 09:07
BRIEF-Cansino Biologics Says It Will Purchase Structured Deposit Of RMB350 Mln
reuters.com · 05/20 10:23
BUZZ-CanSino's HK stock jumps most on record as WHO approves COVID vaccine for emergency use
reuters.com · 05/20 01:57
More
No Data
Learn about the latest financial forecast of CASBF. Analyze the recent business situations of Cansino Biologic through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

42.86%Strong Buy
57.14%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average CASBF stock price target is 27.81 with a high estimate of 51.41 and a low estimate of 21.50.
High51.41
Average27.81
Low21.50
Current 10.85
EPS
Actual
Estimate
0.260.540.811.09
Q1 2021
Q2 2021
Q3 2021
Q4 2021
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.21%
Pharmaceuticals & Medical Research
-0.21%
Key Executives
Chairman/Chief Executive Officer/General Manager/Executive Director
Xuefeng Yu
Chief Financial Officer/Finance Director
Xi Luo
Chief Operating Officer/Deputy General Manager/Executive Director
Shoubai Chao
Deputy General Manager/Executive Director
Wang Jing
Deputy General Manager/Executive Director
Dongxu Qiu
Deputy General Manager
Huihua Mao
Secretary/IR Contact Officer
Jin Cui
Non-Executive Director
Wing-Yu Leung
Non-Executive Director
Liang Lin
Non-Executive Director
Zhi Xiao
Non-Executive Independent Director
Shuifa Gui
Non-Executive Independent Director
Jianzhong Liu
Non-Executive Independent Director
Shiu Kwan Wai
Non-Executive Independent Director
Zhu Xin
No Data
No Data
About CASBF
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.

Webull offers kinds of Cansino Biologics Inc stock information, including OTCPK:CASBF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CASBF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CASBF stock methods without spending real money on the virtual paper trading platform.